Novel selective thiadiazine DYRK1A inhibitor lead scaffold with human pancreatic β-cell proliferation activity
- 1 September 2018
- journal article
- research article
- Published by Elsevier in European Journal of Medicinal Chemistry
- Vol. 157, 1005-1016
Abstract
No abstract availableKeywords
Funding Information
- NIH
- NIDDK (R01DK015015-01-A)
- NIH (UC4 DK104211, P-30 DK 020541)
- JDRF (2-SRA-2015-62)
- Icahn School of Medicine (0285-3980)
- NIH (R01-GM108911, U54-OD020353)
- Swiss National Science Foundation
- Dartmouth University
- NIH/NIDDK
- Diabetes Research Center
- Human Islet Research Network
This publication has 56 references indexed in Scilit:
- ZINC: A Free Tool to Discover Chemistry for BiologyJournal of Chemical Information and Modeling, 2012
- Adenosine kinase inhibition selectively promotes rodent and porcine islet β-cell replicationProceedings of the National Academy of Sciences, 2012
- Structure-based discovery of prescription drugs that interact with the norepinephrine transporter, NETProceedings of the National Academy of Sciences, 2011
- Potent and selective small molecule inhibitors of specific isoforms of Cdc2-like kinases (Clk) and dual specificity tyrosine-phosphorylation-regulated kinases (Dyrk)Bioorganic & Medicinal Chemistry Letters, 2011
- Molecular Docking Screens Using Comparative Models of ProteinsJournal of Chemical Information and Modeling, 2009
- Quinalizarin as a potent, selective and cell-permeable inhibitor of protein kinase CK2Biochemical Journal, 2009
- How well can the accuracy of comparative protein structure models be predicted?Protein Science, 2008
- Statistical potential for assessment and prediction of protein structuresProtein Science, 2006
- T-coffee: a novel method for fast and accurate multiple sequence alignment 1 1Edited by J. ThorntonJournal of Molecular Biology, 2000
- Comparative Protein Modelling by Satisfaction of Spatial RestraintsJournal of Molecular Biology, 1993